Philip Morris Becomes Principal Partner of Ferrari Hypersail
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy PM?
Philip Morris International announced it will serve as Principal Partner of Ferrari Hypersail. "Ferrari's pursuit of record-breaking performance at sea mirrors PMI's own journey of change and innovation - bold, forward-looking, and driven by the conviction that technology, coupled with human ingenuity, can help tackle long-standing challenges," said Jacek Olczak, Group CEO, PMI. "This moment is more than an announcement. It is a continuation of a journey that began more than 50 years ago, charting a new course defined by shared ambition, bold challenges, and a belief that progress matters."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PM
Wall Street analysts forecast PM stock price to rise
11 Analyst Rating
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 156.240
Low
175.00
Averages
191.95
High
210.00
Current: 156.240
Low
175.00
Averages
191.95
High
210.00
About PM
Philip Morris International Inc. is an international tobacco company. The Company’s product portfolio primarily consists of cigarettes and smoke-free products. Its smoke-free business (SFB) also includes wellness and healthcare products, as well as consumer accessories, such as lighters and matches. The Company’s segments include Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region (SSEA, CIS & MEA); East Asia, Australia & PMI Global Travel Retail (EA, AU & PMI GTR), and Americas Region. The Company's brands include Marlboro, HEETS, IQOS, IQOS ILUMA, TEREA, VEEV and ZYN. Its IQOS smoke-free product brand portfolio includes heated tobacco and nicotine-containing vapor products. Its international cigarette brands are Chesterfield, L&M, and Philip Morris. It also owns a number of local cigarette brands, such as Dji Sam Soe and Sampoerna A in Indonesia, and Fortune and Jackpot in the Philippines.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Philip Morris Secures FDA Renewal for Heated Tobacco Product Authorizations
- FDA Renewal Authorization: The U.S. FDA has announced the renewal of Philip Morris's Modified Risk Tobacco Product (MRTP) authorizations for the IQOS and HEETS products, allowing the company to continue sharing reduced exposure information with U.S. adults aged 21 and over, thereby promoting public health.
- Scientific Basis Support: The FDA's decision is based on scientific studies indicating that switching completely from conventional cigarettes to the IQOS system significantly reduces exposure to harmful chemicals, which is expected to improve the overall health of both smokers and non-smokers, further solidifying PMI's leadership in the heated tobacco market.
- Significant Market Potential: PMI aims to provide better smoke-free alternatives to approximately 25 million legal-age smokers in the U.S., with an estimated 43 million legal-age consumers globally using its smoke-free products by 2025, indicating strong market demand and growth potential.
- Ongoing Investment in Innovation: Since 2008, PMI has invested over $16 billion in the development of smoke-free products, focusing on scientific substantiation and commercialization of innovative products, with the goal of completely ending cigarette sales and driving the industry towards healthier alternatives.
See More
Wall Street Earnings Season Faces Major Test
- Earnings Season Significance: Wall Street is set for a packed earnings season featuring key companies like Capital One and Boeing, with investors eager to glean insights into the economic impact of the Iran war from these reports.
- Capital One Performance Focus: Capital One is scheduled to report earnings on Tuesday, with market attention on its consumer health metrics and the progress of its acquisitions of Discover and Brex, particularly amid rising economic uncertainties.
- Boeing Earnings Outlook: Boeing is expected to release its earnings report on Wednesday, with market focus on order volumes in both its commercial and defense sectors, as well as free cash flow performance, especially after previous unexpected losses.
- GE Vernova Order Growth: GE Vernova will report alongside Boeing, with first-quarter new orders anticipated to reach $14.4 billion, reflecting a 65% year-over-year increase, indicating strong market performance amid rising electricity demand.
See More
PHILIP MORRIS - EXTENDED APPROVAL INCLUDES IQOS 2.4, IQOS 3.0, AND HEETS AMBER, GREEN MENTHOL, BLUE MENTHOL
Renewed Authorization: The article discusses the renewed authorization for various IQOS products, specifically IQOS 2.4 and IQOS 3.0.
Product Coverage: It also covers the inclusion of Heets Amber, Green Menthol, and Blue Menthol in the authorization.
See More
PHILIP MORRIS INTERNATIONAL RECEIVES U.S. FDA REAUTHORIZATION FOR IQOS AS A MODIFIED RISK TOBACCO PRODUCT
- FDA Authorization: The U.S. FDA has authorized the use of IQOS as a modified risk tobacco product.
- Impact on Tobacco Products: This decision allows Philip Morris International to market IQOS with reduced risk claims compared to traditional tobacco products.
See More
Wall Street Optimism Rises Amid Ceasefire Hopes
- Market Rebound: The S&P 500 and Nasdaq Composite reached all-time highs this week, with the S&P 500 surpassing 7,100 for the first time, reflecting strong investor confidence in economic recovery and suggesting further upward momentum for equities.
- Earnings Expectations: According to FactSet, the S&P 500 is projected to have a blended growth rate of 12.5% in Q1, with 78% of reporting companies exceeding expectations, providing a positive backdrop for the upcoming earnings season that could further bolster market confidence.
- Oil Price Volatility: While oil prices have fallen to around $80 per barrel, significantly below the $110 peak during the conflict, the market must remain vigilant regarding the potential impacts of U.S.-Iran tensions on global supply chains, particularly concerning the safety of transit through the Strait of Hormuz.
- Technical Fragility: Despite the market's strong short-term performance, analyst Craig Johnson warns that the rapid transition from oversold to overbought conditions masks underlying macroeconomic risks, urging investors to remain cautious and focus on high-quality investment opportunities.
See More
IWD ETF 52-Week Price Fluctuation Analysis
- Price Range Analysis: The IWD ETF has a 52-week low of $171.13 and a high of $227.17, with the last trade at $227.11, indicating the ETF is trading near its high, which may influence investor buying decisions.
- Technical Analysis Tool: Comparing the current price to the 200-day moving average provides investors with a technical analysis reference, helping assess whether the current price is overvalued or undervalued, thus impacting short-term trading strategies.
- ETF Unit Trading Mechanism: ETFs trade like stocks, where investors are actually buying and selling 'units' that can be created or destroyed based on demand, affecting the liquidity and price volatility of the underlying assets.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in ETF units focuses on significant inflows (new units created) or outflows (old units destroyed), which directly impacts the ETF's underlying holdings and market performance.
See More
Philip Morris Secures FDA Renewal for Heated Tobacco Product Authorizations
- FDA Renewal Authorization: The U.S. FDA has announced the renewal of Philip Morris's Modified Risk Tobacco Product (MRTP) authorizations for the IQOS and HEETS products, allowing the company to continue sharing reduced exposure information with U.S. adults aged 21 and over, thereby promoting public health.
- Scientific Basis Support: The FDA's decision is based on scientific studies indicating that switching completely from conventional cigarettes to the IQOS system significantly reduces exposure to harmful chemicals, which is expected to improve the overall health of both smokers and non-smokers, further solidifying PMI's leadership in the heated tobacco market.
- Significant Market Potential: PMI aims to provide better smoke-free alternatives to approximately 25 million legal-age smokers in the U.S., with an estimated 43 million legal-age consumers globally using its smoke-free products by 2025, indicating strong market demand and growth potential.
- Ongoing Investment in Innovation: Since 2008, PMI has invested over $16 billion in the development of smoke-free products, focusing on scientific substantiation and commercialization of innovative products, with the goal of completely ending cigarette sales and driving the industry towards healthier alternatives.
See More
Wall Street Earnings Season Faces Major Test
- Earnings Season Significance: Wall Street is set for a packed earnings season featuring key companies like Capital One and Boeing, with investors eager to glean insights into the economic impact of the Iran war from these reports.
- Capital One Performance Focus: Capital One is scheduled to report earnings on Tuesday, with market attention on its consumer health metrics and the progress of its acquisitions of Discover and Brex, particularly amid rising economic uncertainties.
- Boeing Earnings Outlook: Boeing is expected to release its earnings report on Wednesday, with market focus on order volumes in both its commercial and defense sectors, as well as free cash flow performance, especially after previous unexpected losses.
- GE Vernova Order Growth: GE Vernova will report alongside Boeing, with first-quarter new orders anticipated to reach $14.4 billion, reflecting a 65% year-over-year increase, indicating strong market performance amid rising electricity demand.
See More
PHILIP MORRIS - EXTENDED APPROVAL INCLUDES IQOS 2.4, IQOS 3.0, AND HEETS AMBER, GREEN MENTHOL, BLUE MENTHOL
Renewed Authorization: The article discusses the renewed authorization for various IQOS products, specifically IQOS 2.4 and IQOS 3.0.
Product Coverage: It also covers the inclusion of Heets Amber, Green Menthol, and Blue Menthol in the authorization.
See More
PHILIP MORRIS INTERNATIONAL RECEIVES U.S. FDA REAUTHORIZATION FOR IQOS AS A MODIFIED RISK TOBACCO PRODUCT
- FDA Authorization: The U.S. FDA has authorized the use of IQOS as a modified risk tobacco product.
- Impact on Tobacco Products: This decision allows Philip Morris International to market IQOS with reduced risk claims compared to traditional tobacco products.
See More
Wall Street Optimism Rises Amid Ceasefire Hopes
- Market Rebound: The S&P 500 and Nasdaq Composite reached all-time highs this week, with the S&P 500 surpassing 7,100 for the first time, reflecting strong investor confidence in economic recovery and suggesting further upward momentum for equities.
- Earnings Expectations: According to FactSet, the S&P 500 is projected to have a blended growth rate of 12.5% in Q1, with 78% of reporting companies exceeding expectations, providing a positive backdrop for the upcoming earnings season that could further bolster market confidence.
- Oil Price Volatility: While oil prices have fallen to around $80 per barrel, significantly below the $110 peak during the conflict, the market must remain vigilant regarding the potential impacts of U.S.-Iran tensions on global supply chains, particularly concerning the safety of transit through the Strait of Hormuz.
- Technical Fragility: Despite the market's strong short-term performance, analyst Craig Johnson warns that the rapid transition from oversold to overbought conditions masks underlying macroeconomic risks, urging investors to remain cautious and focus on high-quality investment opportunities.
See More
IWD ETF 52-Week Price Fluctuation Analysis
- Price Range Analysis: The IWD ETF has a 52-week low of $171.13 and a high of $227.17, with the last trade at $227.11, indicating the ETF is trading near its high, which may influence investor buying decisions.
- Technical Analysis Tool: Comparing the current price to the 200-day moving average provides investors with a technical analysis reference, helping assess whether the current price is overvalued or undervalued, thus impacting short-term trading strategies.
- ETF Unit Trading Mechanism: ETFs trade like stocks, where investors are actually buying and selling 'units' that can be created or destroyed based on demand, affecting the liquidity and price volatility of the underlying assets.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in ETF units focuses on significant inflows (new units created) or outflows (old units destroyed), which directly impacts the ETF's underlying holdings and market performance.
See More
